velnacrine has been researched along with tacrine in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (12.96) | 18.7374 |
| 1990's | 35 (64.81) | 18.2507 |
| 2000's | 10 (18.52) | 29.6817 |
| 2010's | 2 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bores, GM; Cornfeldt, ML; Davis, KL; Haroutunian, V; Huger, FP; Kapples, KJ; Pierrat, FA; Shutske, GM; Szewczak, MR | 1 |
| Caprathe, BW; Emmerling, MR; Jaen, JC; Pool, WF; Reily, MD; Woolf, TF | 1 |
| Butterfield, DA; Rangachari, A | 1 |
| Curran, SM; Dougal, NJ; Ebmeier, KP; Goodwin, GM; Hanson, MT; Hunter, R; Murray, CL; Patterson, J; Siegfried, K; Wyper, DJ | 1 |
| Cutler, NR; Murphy, MF; Nash, RJ; Sramek, JJ | 1 |
| Badia, A; Baños, JE; Bosch, F; Morales, M | 2 |
| Braga, MF; Harvey, AL; Rowan, EG | 1 |
| Deptula, D; Pomara, N; Singh, R | 1 |
| Demkovich, JJ; Dobson, C; Hardiman, ST; Huff, FJ; Knappe, UE; Murphy, MF; Nash, RJ | 1 |
| Jertz, G; Murphy, M; Pinker, S; Siegfried, K; Simpson, PM; Wesnes, KA; White, L | 1 |
| Ford, JM; Roberts, CJ; Truman, CA | 1 |
| Ho, I; Hsu, R; Lassman, HB; Puri, SK | 1 |
| Cutler, NR; De Luna, DM; Murphy, MF; Nash, RJ; Prior, PL | 1 |
| Irie, T; Katsube, J; Natori, K; Okazaki, Y | 2 |
| Chesson, SM; DiLeo, EM; Ellis, DB; Hsu, RS; Wichmann, JK | 1 |
| Ekman, L; Lindström, B; Roxin, P | 1 |
| Ho, I; Hsu, RS; Lassman, HB; Puri, SK | 2 |
| Hayashi, S; Sakurai, M; Tanaka, Y | 1 |
| Bores, GM; Cornfeldt, ML; Davis, KL; Haroutunian, V; Huger, FP; Pierrat, FA; Shutske, GM; Szewczak, MR | 1 |
| Buccafusco, JJ; Jackson, WJ; Rush, DK; Terry, AV; Turk, DJ | 1 |
| Clipp, EC; Moore, MJ | 2 |
| Antuono, PG | 1 |
| Acosta, D; al Casey, S; Brewster, D; Viau, C | 1 |
| Schehr, RS | 1 |
| Balogh, L; Brown, RR; Collis, MS; Haughey, DB; Klockowski, PM; McNaney, CA; Siedlik, PH | 1 |
| Siegfried, KR | 1 |
| Hardiman, S; Miller, K; Murphy, M | 1 |
| Beermann, B | 1 |
| Butterfield, DA; Carney, J; Hall, N; Hensley, K; Umhauer, S | 1 |
| Curren, RD; Viau, CJ; Wallace, K | 1 |
| Cutler, NR; Sramek, JJ | 2 |
| Keys, M; Richter, RW; Strub, RL; Zemlan, FP | 1 |
| Citrome, L; Pomara, N | 1 |
| Ford, JM; Roberts, CJ; Wood, DM | 1 |
| Duoyon, E; Lee, WS; Morrishow, AM; Prell, GD | 1 |
| Zemlan, FP | 1 |
| Laine, K; Manninen, P; Palovaara, S; Tapanainen, P | 1 |
| Aparicio, I; Bello, MA; Callejón, M; Guiraúm, A; Jiménez, JC | 2 |
| Cecchetti, V; Filipponi, E; Fravolini, A; Lamperti, MG; Tabarrini, O; Temperini, A | 1 |
| Birks, J; Wilcock, GG | 1 |
| Ahn, SH; Chung, SJ; Hong, SS; Li, H; Park, BS; Park, CH; Seo, SY; Sung, JH | 1 |
| Martins e Silva, J; Saldanha, C; Silva, AS | 1 |
| Almeida, JP; Carvalho, FA; Freitas, T; Saldanha, C | 1 |
| Almeida, JP; Carvalho, FA; Fernandes, IO; Freitas-Santos, T; Saldanha, C | 1 |
| Carvalho, FA; Lopes de Almeida, JP; Saldanha, C; Santos-Freitas, T; Silva-Herdade, AS | 1 |
| Carvalho, FA; de Almeida, JP; Freitas-Santos, T; Saldanha, C | 1 |
| Qian, S; Wo, SK; Zuo, Z | 1 |
| Saldanha, C; Silva-Herdade, AS | 1 |
3 review(s) available for velnacrine and tacrine
| Article | Year |
|---|---|
Pharmacodynamic and early clinical studies with velnacrine.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Placebos; Scopolamine; Tacrine; Tomography, Emission-Computed, Single-Photon | 1993 |
Side effects of long acting cholinesterase inhibitors.
Topics: Alzheimer Disease; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Clinical Trials as Topic; Female; Humans; Liver; Male; Tacrine; Transaminases | 1993 |
Velnacrine for Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Humans; Randomized Controlled Trials as Topic; Tacrine | 2004 |
18 trial(s) available for velnacrine and tacrine
| Article | Year |
|---|---|
Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Physostigmine; Tacrine; Tomography, Emission-Computed, Single-Photon | 1992 |
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Double-Blind Method; Drug Administration Schedule; Humans; Male; Middle Aged; Tacrine | 1992 |
Pretreatment postural blood pressure drop as a possible predictor of response to the cholinesterase inhibitor velnacrine (HP 029) in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Double-Blind Method; Female; Humans; Hypotension, Orthostatic; Male; Supine Position; Tacrine | 1991 |
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Drug Evaluation; Female; Humans; Male; Middle Aged; Placebos; Psychological Tests; Tacrine | 1991 |
Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's disease.
Topics: Administration, Oral; Aged; Alzheimer Disease; Drug Administration Schedule; Drug Evaluation; Half-Life; Humans; Male; Middle Aged; Risk Factors; Tacrine; Time Factors | 1990 |
Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Aminoacridines; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Random Allocation; Risk Factors; Tacrine; Time Factors | 1990 |
The effect of food on the bioavailability of velnacrine (HP 029) in healthy elderly men: a potential Alzheimer agent.
Topics: Aged; Alzheimer Disease; Aminoacridines; Biological Availability; Chromatography, High Pressure Liquid; Electrocardiography; Food; Humans; Intestinal Absorption; Male; Middle Aged; Tacrine | 1989 |
Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent.
Topics: Adult; Alzheimer Disease; Aminoacridines; Double-Blind Method; Drug Evaluation; Drug Tolerance; Humans; Male; Random Allocation; Risk Factors; Tacrine | 1989 |
Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cognition; Double-Blind Method; Female; Humans; Male; Middle Aged; Severity of Illness Index; Tacrine; Time; Treatment Outcome | 1995 |
Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Tacrine; Treatment Outcome | 1995 |
Alzheimer's disease and caregiver time.
Topics: Activities of Daily Living; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Double-Blind Method; Humans; Single-Blind Method; Tacrine; Time Factors; Workload | 1994 |
Pharmacodynamic and early clinical studies with velnacrine.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Placebos; Scopolamine; Tacrine; Tomography, Emission-Computed, Single-Photon | 1993 |
Clinical trials with velnacrine: (PROPP) the physician reference of predicted probabilities--a statistical model for the estimation of hepatotoxicity risk with velnacrine maleate.
Topics: Age Factors; Aged; Alzheimer Disease; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Enzyme Activation; Female; Humans; Liver; Liver Diseases; Male; Models, Statistical; Probability; Sex Factors; Tacrine | 1993 |
The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study".
Topics: Alzheimer Disease; Cholinergic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Physostigmine; Safety; Tacrine | 1995 |
Double-blind placebo-controlled study of velnacrine in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Tacrine | 1996 |
Variability in the plasma protein binding of velnacrine (1-hydroxy tacrine hydrochloride). A potential agent for Alzheimer's disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Binding, Competitive; Blood Proteins; Cholinesterase Inhibitors; Female; Humans; Male; Orosomucoid; Protein Binding; Serum Albumin; Tacrine | 1996 |
Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Placebos; Tacrine; Treatment Outcome | 1996 |
Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy.
Topics: Adult; Cholinesterase Inhibitors; Cross-Over Studies; Cytochrome P-450 CYP1A2; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxylation; Levonorgestrel; Nootropic Agents; Progesterone Congeners; Reference Values; Tacrine | 1999 |
34 other study(ies) available for velnacrine and tacrine
| Article | Year |
|---|---|
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
Topics: Alzheimer Disease; Aminoacridines; Animals; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Male; Memory; Mice; Rats; Rats, Inbred Strains; Scopolamine; Structure-Activity Relationship; Tacrine | 1989 |
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacology.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Hydroxylation; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Structure; Rats; Tacrine | 1996 |
Membrane-altering effects of velnacrine and N-methylacridinium: relevance to tacrine and Alzheimer's disease.
Topics: Acridines; Alzheimer Disease; Cytoskeletal Proteins; Cytoskeleton; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Humans; In Vitro Techniques; Protein Binding; Structure-Activity Relationship; Tacrine | 1992 |
Effects of velnacrine, tacrine and physostigmine on tetanic twitch responses at the rat neuromuscular junction.
Topics: Animals; Cholinesterase Inhibitors; Diaphragm; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Neuromuscular Junction; Phrenic Nerve; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine | 1992 |
Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro.
Topics: 4-Aminopyridine; Acetylcholine; Acetylcholinesterase; Action Potentials; Amifampridine; Aminoacridines; Animals; Calcium; Chick Embryo; Cholinesterase Inhibitors; Electrophysiology; In Vitro Techniques; Magnesium; Male; Mice; Mice, Inbred BALB C; Motor Endplate; Neuromuscular Junction; Respiratory Muscles; Synaptic Transmission; Tacrine | 1991 |
Cholinesterase inhibition in the scopolamine model of dementia.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Humans; Memory; Scopolamine; Tacrine | 1991 |
Comparison of the chromatographic characteristics of metabolites of tacrine hydrochloride in human serum and urine with those of in vitro metabolic products from hepatic microsomes.
Topics: Animals; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Humans; Male; Microsomes, Liver; Rats; Rats, Inbred Strains; Tacrine | 1991 |
Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor.
Topics: Aminacrine; Aminoacridines; Aminoquinolines; Animals; Body Temperature; Cerebral Cortex; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Mice; Nucleic Acids; Physostigmine; Rats; Salivation; Tacrine | 1990 |
Effect of a novel CNS-selective cholinesterase inhibitor, SM-10888, on habituation and passive avoidance responses in mice.
Topics: Aminacrine; Aminoacridines; Aminoquinolines; Animals; Avoidance Learning; Cholinesterase Inhibitors; Cycloheximide; Electroshock; Exploratory Behavior; Habituation, Psychophysiologic; Male; Mice; Physostigmine; Tacrine | 1990 |
Determination of velnacrine in plasma and urine by high-performance liquid chromatography.
Topics: Aminoacridines; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Humans; Tacrine | 1989 |
Determination of tacrine and its 1-hydroxy metabolite in plasma using column liquid chromatography with ultraviolet detection.
Topics: Aminoacridines; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Humans; Spectrophotometry, Ultraviolet; Tacrine | 1989 |
Effect of scopolamine and HP 029, a cholinesterase inhibitor, on long-term potentiation in hippocampal slices of the guinea pig.
Topics: Action Potentials; Aminoacridines; Animals; Cholinergic Fibers; Cholinesterase Inhibitors; Electric Stimulation; Guinea Pigs; Hippocampus; In Vitro Techniques; Male; Scopolamine; Tacrine; Time Factors | 1989 |
(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
Topics: Alzheimer Disease; Aminoacridines; Animals; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Humans; Mice; Rats; Tacrine | 1988 |
Velnacrine maleate improves delayed matching performance by aged monkeys.
Topics: Aging; Alzheimer Disease; Animals; Behavior, Animal; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Maleates; Memory; Tacrine; Time Factors | 1995 |
Effect of glutathione depletion and oxidative stress on the in vitro cytotoxicity of velnacrine maleate.
Topics: Alzheimer Disease; Animals; Cells, Cultured; Cholinesterase Inhibitors; Fluorescent Dyes; Formazans; Glutathione; L-Lactate Dehydrogenase; Liver; Neutral Red; Oxidation-Reduction; Oxidative Stress; Peroxides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tacrine; tert-Butylhydroperoxide; Tetrazolium Salts | 1995 |
Therapeutic approaches to Alzheimer's disease. An informal survey of promising drug discovery strategies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Drug Design; Humans; Neurotransmitter Agents; Tacrine | 1994 |
Simultaneous determination of tacrine and 1-hydroxy-, 2-hydroxy-, and 4-hydroxytacrine in human plasma by high-performance liquid chromatography with fluorescence detection.
Topics: Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Humans; Quality Control; Spectrometry, Fluorescence; Tacrine | 1994 |
Interaction of tacrine and velnacrine with neocortical synaptosomal membranes: relevance to Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cytoskeletal Proteins; Electron Spin Resonance Spectroscopy; Gerbillinae; Male; Rats; Rats, Sprague-Dawley; Synaptic Membranes; Synaptosomes; Tacrine | 1993 |
Comparative effects of velnacrine, tacrine and physostigmine on the twitch responses in the rat phrenic-hemidiaphragm preparation.
Topics: Animals; Cholinesterase Inhibitors; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Neuromuscular Blocking Agents; Neuromuscular Junction; Phrenic Nerve; Physostigmine; Rats; Rats, Sprague-Dawley; Respiratory Muscles; Tacrine | 1993 |
Cytotoxicity of tacrine and velnacrine metabolites in cultured rat, dog and human hepatocytes.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Dogs; Female; Humans; L-Lactate Dehydrogenase; Liver; Liver Diseases; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344; Sensitivity and Specificity; Tacrine; Tumor Cells, Cultured | 1993 |
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dihydropyridines; Ethics, Medical; Humans; Nootropic Agents; Oximes; Physostigmine; Psychotropic Drugs; Pyridines; Tacrine; Thiadiazoles | 1995 |
Transient elevations in pancreatic enzymes in response to a cholinesterase inhibitor.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Humans; Male; Middle Aged; Pancreas; Tacrine | 1995 |
Inhibitors of histamine methylation in brain promote formation of imidazoleacetic acid, which interacts with GABA receptors.
Topics: Animals; Brain; Gas Chromatography-Mass Spectrometry; Histamine; Imidazoles; Male; Methylation; Physostigmine; Pyrimethamine; Rats; Rats, Sprague-Dawley; Receptors, GABA; Tacrine | 1997 |
Electrochemical oxidation at carbon paste electrode of tacrine and 1-hydroxytacrine and differential pulse voltammetric determination of tacrine in pharmaceuticals and human urine.
Topics: Carbon; Electrochemistry; Electrodes; Humans; Tacrine | 2000 |
Velnacrine thiaanalogues as potential agents for treating Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Animals; Avoidance Learning; Blood Cells; Chlorine; Cholinesterase Inhibitors; Humans; Inhibitory Concentration 50; Male; Mice; Models, Molecular; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfur; Survival Rate; Tacrine | 2001 |
Spectrofluorimetric determination of velnacrine in human serum and urine.
Topics: Humans; Spectrometry, Gamma; Tacrine | 2003 |
Mechanism for increased bioavailability of tacrine in fasted rats.
Topics: Administration, Oral; Animals; Biological Availability; Cholinesterase Inhibitors; Fasting; Injections, Intravenous; Intestinal Absorption; Male; Permeability; Rats; Rats, Sprague-Dawley; Tacrine | 2006 |
Effects of velnacrine maleate in the leukocyte-endothelial cell interactions in rat cremaster microcirculatory network.
Topics: Acetylcholine; Alzheimer Disease; Animals; Blood Pressure; Cholinesterase Inhibitors; Endothelium, Vascular; Interleukin-1beta; Leukocyte Rolling; Leukocytes; Male; Microcirculation; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Scrotum; Tacrine; Venules | 2007 |
Modulation of hemorheological parameters by the erythrocyte redox thiol status.
Topics: Acetylcholine; Acetylcholinesterase; Cholinergic Agents; Cholinesterase Inhibitors; Dithiothreitol; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Hematologic Diseases; Humans; Male; Membrane Fluidity; Microcirculation; Oxidation-Reduction; Tacrine | 2008 |
Non-neuronal cholinergic system and signal transduction pathways mediated by band 3 in red blood cells.
Topics: Acetylcholine; Acetylcholinesterase; Anion Exchange Protein 1, Erythrocyte; Cholinesterase Inhibitors; Erythrocytes; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Intracellular Signaling Peptides and Proteins; Nitric Oxide; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-hck; Signal Transduction; src-Family Kinases; Syk Kinase; Tacrine | 2008 |
Redox thiol status plays a central role in the mobilization and metabolism of nitric oxide in human red blood cells.
Topics: Acetylcholine; Acetylcholinesterase; Cholinesterase Inhibitors; Dithiothreitol; Erythrocytes; Humans; Nitric Oxide; Oxidation-Reduction; Peroxynitrous Acid; S-Nitrosoglutathione; Tacrine | 2009 |
Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions.
Topics: Acetylcholinesterase; Anion Exchange Protein 1, Erythrocyte; Blotting, Western; Dipeptides; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Erythrocytes; GTP-Binding Protein alpha Subunits; GTP-Binding Protein beta Subunits; GTP-Binding Proteins; Humans; Immunoprecipitation; Male; Protein Binding; Tacrine | 2009 |
Pharmacokinetics and brain dispositions of tacrine and its major bioactive monohydroxylated metabolites in rats.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Male; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Tacrine | 2012 |
Effects of acetylcholine on an animal mode of inflammation.
Topics: Acetylcholine; Animals; Cell Movement; Cholinesterase Inhibitors; Endothelium, Vascular; Inflammation; Leukocytes; Lipopolysaccharides; Male; Microscopy; Rats; Rats, Wistar; Tacrine; Tumor Necrosis Factor-alpha | 2013 |